The primary mechanism of action of most anticancer dugs are known and many induce apoptosis. However, there are large gaps in our knowledge of anticancer drug action, in particular how damage and apoptosis are molecularly linked. Furthermore, cell death does not always follow damage, and cancer cells can survive exposure to cytotoxic drugs through defective apoptosis, other resistance mechanisms, or repair. An understanding of the mechanisms that link damage to response may suggest ways to alter the threshold for cell death to make cancer cells more sensitive to chemotherapeutic drugs. Recently, we have shown that Adriamycin, vinblastine, or etoposide activate c-Jun NH2-terminal protein kinase (JNK), a stress-activated protein kinase, in human KB carcinoma cells. Our hypothesis is that JNK-mediated signaling is a critical component of the stress response to functionally distinct anticancer drugs that might affect outcome by influencing or mediating cell death or cell survival.
In Specific Aim 1, the substrates (transcription factors) and effectors (transcriptional activators) of JNK in response to chemotherapeutic drugs will be determined. This will provide a comprehensive picture of molecular events emanating downstream from JNK that may be critical to the overall response to chemotherapy.
In Specific Aim 2, several approaches (JNK antisense oligonucleotides, JNK phosphatase overexpression, dominant negative inhibitors of SEK1, Jun or ATF-2) will be used to generate human carcinoma cell lines with defective JNK signaling in response to chemotherapeutic drugs.
In Specific Aim 3, the JNK signaling-defective cell lines will be used to explore the mechanistic relationship between JNK activation and apoptotic cell death in response to chemotherapeutic drugs. In particular, it will be determined whether JNK regulates the expression or activity of apoptotic regulators (Bcl-2 family) or apoptotic effects (caspases).
In Specific Aim 4, it will be determined whether JNK plays a role in cell survival through regulation of MDR1 expression. By understanding the role of JNK in the response of carcinoma cells to anticancer drugs, we may be able to develop methods to manipulate this signaling pathway in order to increase drug sensitivity or prevent drug resistance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA075577-01A1
Application #
2606596
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Johnson, George S
Project Start
1998-04-01
Project End
2002-01-31
Budget Start
1998-04-01
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Bateman, T David; Joshi, Aarti L; Moon, Kwangyul et al. (2009) Synthesis and anticancer activity of sclerophytin-inspired hydroisobenzofurans. Bioorg Med Chem Lett 19:6898-901
Upreti, Meenakshi; Chu, Rong; Galitovskaya, Elena et al. (2008) Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine. Mol Cancer Ther 7:2224-32
Kolomeichuk, Sergey N; Terrano, David T; Lyle, Christopher S et al. (2008) Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. FEBS J 275:1889-99
Duan, Lingling; Sterba, Kristen; Kolomeichuk, Sergey et al. (2007) Inducible overexpression of c-Jun in MCF7 cells causes resistance to vinblastine via inhibition of drug-induced apoptosis and senescence at a step subsequent to mitotic arrest. Biochem Pharmacol 73:481-90
Upreti, Meenakshi; Lyle, Christopher S; Skaug, Brian et al. (2006) Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. J Biol Chem 281:15941-50
Zharov, Vladimir P; Galitovskiy, Valentin; Lyle, Christopher S et al. (2006) Superhigh-sensitivity photothermal monitoring of individual cell response to antitumor drug. J Biomed Opt 11:064034
Kurten, Richard C; Chowdhury, Parag; Sanders Jr, Ronald C et al. (2005) Coordinating epidermal growth factor-induced motility promotes efficient wound closure. Am J Physiol Cell Physiol 288:C109-21
Obey, Toria B; Lyle, Christopher S; Chambers, Timothy C (2005) Role of c-Jun in cellular sensitivity to the microtubule inhibitor vinblastine. Biochem Biophys Res Commun 335:1179-84
Du, Lihua; Lyle, Christopher S; Chambers, Timothy C (2005) Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene 24:107-17
Bene, Anca; Kurten, Richard C; Chambers, Timothy C (2004) Subcellular localization as a limiting factor for utilization of decoy oligonucleotides. Nucleic Acids Res 32:e142

Showing the most recent 10 out of 20 publications